Literature DB >> 17484818

Critical limb ischemia.

David L Dawson1, Joseph L Mills.   

Abstract

Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery disease (PAD). Without timely recognition, appropriate diagnosis, and revascularization, patients with CLI are at risk for amputation or potentially fatal complications. The past decade has seen substantial growth in endovascular CLI therapies and options now exist for treating long-segment lower-extremity arterial occlusive disease, but surgical bypass may yield more durable results. Patients who are younger, more active, and at low risk for surgery may have better outcomes with an operation. Surgical treatment is also indicated for failures of endovascular therapy, which may include early technical failures or later occlusion after placement of stents or other interventions.

Entities:  

Year:  2007        PMID: 17484818     DOI: 10.1007/s11936-007-0009-2

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  56 in total

1.  Peripheral arterial occlusive disease: clinical data for decision making. Introduction.

Authors:  J Dormandy; L Heeck; S Vig
Journal:  Semin Vasc Surg       Date:  1999-06       Impact factor: 1.000

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients.

Authors:  Christopher D Leville; Vikram S Kashyap; Daniel G Clair; James F Bena; Sean P Lyden; Roy K Greenberg; Patrick J O'Hara; Timur P Sarac; Kenneth Ouriel
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

Review 4.  Duplex sonography of lower extremity arteries.

Authors:  R E Zierler; B K Zierler
Journal:  Semin Ultrasound CT MR       Date:  1997-02       Impact factor: 1.875

5.  Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.

Authors:  Amritha Raghunathan; Joseph H Rapp; Fred Littooy; Steven Santilli; William C Krupski; Herbert B Ward; Lizy Thottapurathu; Thomas Moritz; Edward O McFalls
Journal:  J Vasc Surg       Date:  2006-06       Impact factor: 4.268

6.  Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses.

Authors:  P Peeters; J Verbist; K Deloose; M Bosiers
Journal:  J Cardiovasc Surg (Torino)       Date:  2006-08       Impact factor: 1.888

7.  Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial.

Authors:  John R Laird; Thomas Zeller; Bruce H Gray; Dierk Scheinert; Mitar Vranic; Christopher Reiser; Giancarlo Biamino
Journal:  J Endovasc Ther       Date:  2006-02       Impact factor: 3.487

Review 8.  Antibiotic selection for diabetic foot infections: a review.

Authors:  B A Cunha
Journal:  J Foot Ankle Surg       Date:  2000 Jul-Aug       Impact factor: 1.286

Review 9.  Control of infection in the diabetic foot: the role of microbiology, immunopathology, antibiotics, and guillotine amputation.

Authors:  K E McIntyre
Journal:  J Vasc Surg       Date:  1987-05       Impact factor: 4.268

Review 10.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

View more
  4 in total

1.  Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.

Authors:  Sanjay Misra; Robert Lookstein; John Rundback; Alan T Hirsch; William R Hiatt; Michael R Jaff; Christopher R White; Michael Conte; Patrick Geraghty; Manesh Patel; Kenneth Rosenfield
Journal:  J Vasc Interv Radiol       Date:  2013-04       Impact factor: 3.464

2.  Critical limb ischaemia in a diabetic population from an Asian Centre: angiographic pattern of disease and 3-year limb salvage rate with percutaneous angioplasty as first line of treatment.

Authors:  M Tan; U Pua; D E S Wong; S J Punamiya; G C Chua; N Teo
Journal:  Biomed Imaging Interv J       Date:  2010-10-01

3.  Serum nesfatin-1 is reduced in type 2 diabetes mellitus patients with peripheral arterial disease.

Authors:  Shimei Ding; Wei Qu; Shuangsuo Dang; Xuan Xie; Jing Xu; Yuhuan Wang; Aiyu Jing; Chunhong Zhang; Junhong Wang
Journal:  Med Sci Monit       Date:  2015-04-04

4.  AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia.

Authors:  Han-Tan Chai; Hon-Kan Yip; Cheuk-Kwan Sun; Shu-Yuan Hsu; Steve Leu
Journal:  J Inflamm (Lond)       Date:  2016-06-04       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.